Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation
Figure 7.Clinical evaluation of m6A score. Survival analysis of different m6Ascore groups among thyroid cancer patients with Age (A), Gender (B), tumor Stage (C), T stage (D), N stage (E), and M stage (F).